SCHEMBL25410052

SCHEMBL25410052

Cc1cccc(CC2CCC3(CC2)CN(C(=O)O)C3)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.49
FFAR4 Q5NUL3 1/20 0.47
CHRM2 P08172 1/20 0.44
CHRM3 P20309 1/20 0.44
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
MGLL Q99685 1/20 0.42
ABHD6 Q9BV23 1/20 0.42
SSTR1 P30872 1/20 0.42
SSTR4 P31391 1/20 0.42
MCHR1 Q99705 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTR2B P41595 1/20 0.41
MAPK14 Q16539 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25435508 0.93 FFAR4 (0.46) FAAHFFAR4CHRM2CHRM3MAPT
SCHEMBL29426995 0.84 GPR119 (0.47) FAAHFFAR4MAPTMGLLABHD6
SCHEMBL26631468 0.84 GPR119 (0.47) FAAHFFAR4MAPTMGLLABHD6
SCHEMBL26631108 0.83 FAAH (0.41) FAAHFFAR4CHRM2CHRM3MAPT
SCHEMBL26738971 0.83 FAAH (0.41) FAAHFFAR4CHRM2CHRM3MAPT
SCHEMBL26744931 0.82 FAAH (0.41) FAAHFFAR4CHRM2CHRM3MAPT
SCHEMBL29426933 0.78 MGLL (0.40) FAAHFFAR4CHRM2CHRM3POLB
SCHEMBL25411376 0.78 GPR119 (0.46) FAAHFFAR4MAPTKDM4E
SCHEMBL29427074 0.78 GPR119 (0.46) FAAHFFAR4MAPTKDM4E
SCHEMBL26738995 0.78 MGLL (0.40) FAAHFFAR4CHRM2CHRM3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208902-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-06-27 US disclosed
US-11802111-B2 Cyclobutyl amide monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-10-31 US disclosed
EP-4217062-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-08-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208902-A1 CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS MGLL, LPL, PNLIP FAAH 9/4885FFAR4 130/4885CHRM2 622/4885
US-11802111-B2 Cyclobutyl amide monoacylglycerol lipase modulators MGLL, LPL, PNLIP FAAH 8/4885FFAR4 125/4885CHRM2 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.